Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims

INTRODUCTION: There is limited real-world evidence on the treatments for atopic dermatitis (AD) since dupilumab was approved in 2017. The objective of this study was to assess market share of drugs commonly prescribed for the treatment of AD and describe treatment patterns in patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenske, Christian, Boytsov, Natalie, Guo, Jiaying, Dawson, Zach
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056466/
https://www.ncbi.nlm.nih.gov/pubmed/35287230
http://dx.doi.org/10.1007/s12325-022-02071-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056466/
https://www.ncbi.nlm.nih.gov/pubmed/35287230
http://dx.doi.org/10.1007/s12325-022-02071-y

Ejemplares similares